CTOs on the Move

NeoGenomics

www.neogenomics.com

 
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.neogenomics.com
  • 12701 Commonwealth Drive Suite 9
    Fort Myers, FL USA 33913
  • Phone: 239.768.0600
  • Fax: 239.690.4237

Executives

Name Title Contact Details
Warren Stone
President and Chief Operating Officer Profile
Greg Sparks
Chief Technology Officer Profile

Jobs

Funding

NeoGenomics raised $200M on 05/05/2021

Similar Companies

Pace Analytical Services Inc

Pace Analytical Services Inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PSI Inc

PSI Inc is a Escondido, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jamescare In Dublin

Jamescare In Dublin is a Dublin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gainesville Radiology Group

Gainesville Radiology Group is a Gainesville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProLung Incorporated

ProLung`s mission is to make a difference in time for lung cancer patients. ProLung is a leader in innovative predictive analytics technology and non-invasive biomarkers for the risk stratification of lung cancer. The Company develops, tests, and commercializes solutions which may shorten the time to diagnosis and expand the therapeutic window for lung cancer patients.